You just read:

Capricor Therapeutics Awarded $2.4 Million from U.S. Department of Defense to Support Manufacturing Process Development for Therapeutic Exosomes

News provided by

Capricor Therapeutics, Inc.

26 Sep, 2016, 07:00 ET